AVTRNYSELaboratory Analytical InstrumentsFiscal year ends December 31
Avantor, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$16.29−0.13 (-0.79%)
Close on Oct 19, 2026
- Market cap
- $11.03B
- P/E (TTM)
- –
- Dividend yield
- –
Avantor, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VWR Distribution & Services | $1.24B | $1.15B | – | – | $1.21B | $1.16B | – | – | – | – | – | – | 73.3% | +2.7% |
| Bioscience & Medtech Products | $451.80M | $431.40M | – | – | $475.90M | $426.40M | – | – | – | – | – | – | 26.7% | -5.1% |
| AMEA | – | – | – | – | – | – | – | – | – | – | – | $121.20M | – | – |
| Europe | – | – | – | – | – | – | – | – | – | – | – | $579.80M | – | – |
| Americas | – | – | – | – | – | – | – | – | – | – | – | $1.02B | – | – |
| Bioscience Production | – | – | $547.50M | $527.30M | $561.30M | $516.40M | $560.80M | $542.90M | $547.10M | $522.70M | $540.40M | $561.10M | – | – |
| Laboratory Solutions | – | – | $1.12B | $1.10B | $1.12B | $1.07B | $1.13B | $1.17B | $1.16B | $1.16B | $1.18B | $1.16B | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proprietary | $880.40M | $833.30M | $869.80M | $855.60M | $893.80M | $829.70M | $897.10M | $920.50M | $914.00M | $883.50M | $922.30M | $921.80M | 52.0% | -1.5% |
| Third-party | $811.90M | $748.10M | $793.80M | $768.20M | $789.60M | $751.70M | $789.50M | $793.90M | $788.80M | $796.30M | $800.50M | $798.40M | 48.0% | +2.8% |
| Equipment & instrumentation | – | – | – | – | – | – | – | – | – | – | $245.40M | $219.80M | – | – |
| Services & specialty procurement | – | – | – | – | – | – | – | – | – | – | $251.10M | $238.60M | – | – |
By region
From the segment and revenue-disaggregation notes of Avantor's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.